Publications by authors named "Ashley Shoemaker"

Claim this Profile
H
Hyperphagia in Bardet-Biedl syndrome: Pathophysiology, burden, and management.
Philip L Beales, Metin Cetiner, Andrea M Haqq, Jennifer Miller, Ashley H Shoemaker

Obes Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural History of Hyperphagia in Patients with Pseudohypoparathyroidism.
Jaclyn Tamaroff, Ashley H Shoemaker

J Clin Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel model of childhood appetitive traits in children with obesity.
Sunaina Nigam, Mengqi Zhu, Ashley H Shoemaker, Amy C Gross, Claudia K Fox

Int J Obes (Lond)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Model of Childhood Appetitive Traits in Children with Obesity.
Vidhu Thaker, Sunaina Nigam, Mengqi Zhu, Ashley Shoemaker, Amy Gross

Res Sq· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of resting energy expenditure for adolescents with severe obesity: A multi-centre analysis.
Amy A Rydin, Cameron Severn, Laura Pyle, Nazeen Morelli, Ashley H Shoemaker

Pediatr Obes· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial.
Christian L Roth, Cecilia Scimia, Ashley H Shoemaker, Michael Gottschalk, Jennifer Miller

Lancet Diabetes Endocrinol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bardet-Biedl syndrome: A clinical overview focusing on diagnosis, outcomes and best-practice management.
Ashley Shoemaker

Diabetes Obes Metab· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study.
Jennifer L Miller, Evelien Gevers, Nicola Bridges, Jack A Yanovski, Parisa Salehi, Ashley H Shoemaker

Obesity (Silver Spring)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of genetic causes of obesity in clinical practice.
Jaclyn Tamaroff, Dylan Williamson, James C Slaughter, Meng Xu, Gitanjali Srivastava, Ashley H Shoemaker

Obes Sci Pract· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Progression to Type 2 Diabetes in a Pediatric Prediabetes Clinic Population.
Natasha Belsky, Jaclyn Tamaroff, Ashley H Shoemaker

J Endocr Soc· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial.
Jennifer L Miller, Evelien Gevers, Nicola Bridges, Jack A Yanovski, Parisa Salehi, Ashley H Shoemaker

J Clin Endocrinol Metab· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approach to the Patient With Hypothalamic Obesity.
Ashley H Shoemaker, Jaclyn Tamaroff

J Clin Endocrinol Metab· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Coronavirus Disease 2019 Pandemic is Associated with a Substantial Rise in Frequency and Severity of Presentation of Youth-Onset Type 2 Diabetes.
Sheela N Magge, Risa M Wolf, Laura Pyle, Elizabeth A Brown, Valeria C Benavides, Ashley H Shoemaker

J Pediatr· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged lapses between pediatric and adult care are associated with rise in HbA1c and inpatient days among patients with type 1 diabetes.
Daniel R Tilden, Benjamin French, Ashley H Shoemaker, Sarah Corathers, Sarah S Jaser

Diabetes Res Clin Pract· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phentermine/Topiramate for the Treatment of Adolescent Obesity.
Aaron S Kelly, Megan O Bensignor, Daniel S Hsia, Ashley H Shoemaker, Winnie Shih

NEJM Evid· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi Syndrome.
Jennifer L Miller, André Lacroix, Lynne M Bird, Ashley H Shoemaker, Andrea Haqq

J Clin Endocrinol Metab· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Energy balance in hypothalamic obesity in response to treatment with a once-weekly GLP-1 receptor agonist.
Ashley H Shoemaker, Heidi J Silver, Maciej Buchowski, James C Slaughter, Jack A Yanovski

Int J Obes (Lond)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcitriol and Levothyroxine Dosing for Patients With Pseudohypoparathyroidism.
Jacqueline Antoun, Dylan Williamson, Merla Hubler, Ashley H Shoemaker

J Endocr Soc· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Ethnic Disparities in Comorbidities in Youth With Type 2 Diabetes in the Pediatric Diabetes Consortium (PDC).
Fida Bacha, Peiyao Cheng, Robin L Gal, Lindsey C Beaulieu, Craig Kollman, Ashley H Shoemaker

Diabetes Care· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients.
Giovanna Mantovani, Murat Bastepe, David Monk, Luisa de Sanctis, Susanne Thiele, Ashley H Shoemaker

Horm Res Paediatr· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI measures of hypothalamic injury are associated with glucagon-like peptide-1 receptor agonist treatment response in people with hypothalamic obesity.
Francisco A Perez, Clinton Elfers, Jack A Yanovski, Ashley H Shoemaker, M Jennifer Abuzzahab

Diabetes Obes Metab· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Laparoscopic Peritoneal Dialysis Catheter Placement Using an Optimal Placement Technique.
Brandon Smith, Shayda Mirhaidari, Ashley Shoemaker, Deborah Douglas, Adrian G Dan

JSLS· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity.
Christian L Roth, Francisco A Perez, Kathryn B Whitlock, Clinton Elfers, Jack A Yanovski, Ashley H Shoemaker

Diabetes Obes Metab· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the MC4R gene across eMERGE network identifies many unreported obesity-associated variants.
Bahram Namjou, Ian B Stanaway, Todd Lingren, Frank D Mentch, Barbara Benoit, Ashley H Shoemaker

Int J Obes (Lond)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reoperations for Long-Term Complications Following Laparoscopic Adjustable Gastric Banding: Analysis of Incidence and Causality.
Logan T Mellert, Maureen Cheung, Lindsay Berbiglia, Ashley Shoemaker, Deborah Douglas

Cureus· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis